Viardot, A., Wais, V., Sala, E., & Koerper, S. (2019). Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: Perspectives on the therapeutic potential of Axicabtagene ciloleucel. Cancer Manag Res.
Citação norma ChicagoViardot, Andreas, Verena Wais, Elisa Sala, and Sixten Koerper. "Chimeric Antigen Receptor (CAR) T-cell Therapy As a Treatment Option for Patients With B-cell Lymphomas: Perspectives On the Therapeutic Potential of Axicabtagene Ciloleucel." Cancer Manag Res 2019.
Deismireacht MLAViardot, Andreas, Verena Wais, Elisa Sala, and Sixten Koerper. "Chimeric Antigen Receptor (CAR) T-cell Therapy As a Treatment Option for Patients With B-cell Lymphomas: Perspectives On the Therapeutic Potential of Axicabtagene Ciloleucel." Cancer Manag Res 2019.